Guy J. Georges

Penzberg, BY, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 60 publications

Engineering of acidic pH-responsive anti-CD3 binding antibodies.

Engineering of acidic pH-responsive anti-CD3 binding antibodies.

Journal: mAbs

Published: April 28, 2026

Balancing the extremes for antibody developability: hydrophobic and electrostatic germline framework signatures for CDR-loop compensation.

Balancing the extremes for antibody developability: hydrophobic and electrostatic germline framework signatures for CDR-loop compensation.

Journal: mAbs

Published: February 13, 2026

Data-driven analyses of human antibody variable domain germlines: pairings, sequences and structural features.

Data-driven analyses of human antibody variable domain germlines: pairings, sequences and structural features.

Journal: mAbs

Published: May 25, 2025

Predicting the conformational flexibility of antibody and T cell receptor complementarity-determining regions.

Predicting the conformational flexibility of antibody and T cell receptor complementarity-determining regions.

Journal: Nature machine intelligence

Published: March 26, 2025

Improved targeted delivery of antisense oligonucleotide with an antibody mask.

Improved targeted delivery of antisense oligonucleotide with an antibody mask.

Journal: Nucleic acids research

Published: August 08, 2024

Procollagen-lysine 2-oxoglutarate 5-dioxygenases are responsible for 5R-hydroxylysine modification of therapeutic T-cell bispecific monoclonal antibodies produced by Chinese hamster ovary cells.

Procollagen-lysine 2-oxoglutarate 5-dioxygenases are responsible for 5R-hydroxylysine modification of therapeutic T-cell bispecific monoclonal antibodies produced by Chinese hamster ovary cells.

Journal: Frontiers in bioengineering and biotechnology

Published: April 08, 2024

CD19-CD28: an affinity-optimized CD28 agonist for combination with glofitamab (CD20-TCB) as off-the-shelf immunotherapy.

CD19-CD28: an affinity-optimized CD28 agonist for combination with glofitamab (CD20-TCB) as off-the-shelf immunotherapy.

Journal: Blood

Published: November 27, 2023

PEP-Patch: Electrostatics in Protein-Protein Recognition, Specificity, and Antibody Developability.

PEP-Patch: Electrostatics in Protein-Protein Recognition, Specificity, and Antibody Developability.

Journal: Journal of chemical information and modeling

Published: November 07, 2023

Targeted chain-exchange-mediated reconstitution of a split type-I cytokine for conditional immunotherapy.

Targeted chain-exchange-mediated reconstitution of a split type-I cytokine for conditional immunotherapy.

Journal: mAbs

Published: August 23, 2023

The Patent and Literature Antibody Database (PLAbDab): an evolving reference set of functionally diverse, literature-annotated antibody sequences and structures.

The Patent and Literature Antibody Database (PLAbDab): an evolving reference set of functionally diverse, literature-annotated antibody sequences and structures.

Journal: Nucleic acids research

Published: July 26, 2023

Improved computational epitope profiling using structural models identifies a broader diversity of antibodies that bind to the same epitope.

Improved computational epitope profiling using structural models identifies a broader diversity of antibodies that bind to the same epitope.

Journal: Frontiers in molecular biosciences

Published: June 09, 2023

Assessing developability early in the discovery process for novel biologics.

Assessing developability early in the discovery process for novel biologics.

Journal: mAbs

Published: February 23, 2023

Showing 1-12 of 60

Last Updated: 09/26/2026